Search - tctmd.com

Displaying 441 - 460 of 3384

Sort: Relevancy | Date

Presentation TCT 2024

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

Presenter: Pamela Ropski

October 29, 2024

Presentation TCT 2024

TCT 599: The Prognostic Role of a Novel Computational Approach Assessing Microcirculatory Resistance Based on a Single Angiographic View in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Yang Chen

October 29, 2024

Presentation TCT 2024

The Topaz TTVR System: Technology for Expanded Access and EFS Update

Presenter: Hendrik Treede

October 29, 2024

Presentation TCT 2024

The MonarQ TTVR First-in-Human Experience

Presenter: Arshad Quadri

October 29, 2024

Presentation TCT 2024

The Trisol TTVR System: Technology Differentiation and Early Clinical Experience

Presenter: Isaac George

October 29, 2024

Presentation TCT 2024

The Laplace TTVR System

Presenter: Pradeep Yadav

October 29, 2024

Presentation TCT 2024

TCT 131: In-Hospital, 1-Year and Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients Requiring Permanent Pacemaker Implantation

Presenter: Sindhuja Palle

October 29, 2024

Presentation TCT 2024

The LuX-Valve Plus Transjugular TTVR System: One-Year Outcomes of a Multicenter Clinical Study in High Surgical Risk TR Patients

Presenter: Juan Granada

October 29, 2024

Presentation TCT 2024

The Intrepid TTVR Clinical Program

Presenter: Firas Zahr

October 29, 2024

Presentation TCT 2024

TCT 132: Impact of Comorbid Heart Failure With Reduced Ejection Fraction (HFrEF) in the Development of Arrhythmias Among Patients Hospitalized for Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Bruce Adrian Casipit

October 29, 2024

Presentation TCT 2024

The Cardiovalve TTVR Clinical Program

Presenter: Christian Frerker

October 29, 2024

Presentation TCT 2024

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Presenter: Didier Tchetche

October 29, 2024

Presentation TCT 2024

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

Presenter: Thomas Pilgrim

October 29, 2024

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

Presentation TCT 2024

TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Presenter: Usman Akbar

October 29, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Presentation TCT 2024

TCT 1483: LAMPOON-Assisted Transcatheter Mitral Valve-in-Valve Replacement

Presenter: Ganesan Nambirajan

October 28, 2024

Presentation TCT 2024

TCT 338: Clinical and Echocardiographic Predictors of Persistent Mitral Regurgitation Post Transcatheter Aortic Valve Replacement

Presenter: Nawaf Al-Furaih

October 28, 2024

Presentation TCT 2024

TCT 1249: Endovascular Repair for Massive Iliac Vein Perforation During Trans-Septal Mitral Valve-in-Valve Replacement: Which Is the Culprit?

Presenter: Yi Hsin Hung

October 28, 2024

Advertisement

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

TCT 599: The Prognostic Role of a Novel Computational Approach Assessing Microcirculatory Resistance Based on a Single Angiographic View in Patients Undergoing Transcatheter Aortic Valve Replacement

The Topaz TTVR System: Technology for Expanded Access and EFS Update

The MonarQ TTVR First-in-Human Experience

The Trisol TTVR System: Technology Differentiation and Early Clinical Experience

The Laplace TTVR System

TCT 131: In-Hospital, 1-Year and Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients Requiring Permanent Pacemaker Implantation

The LuX-Valve Plus Transjugular TTVR System: One-Year Outcomes of a Multicenter Clinical Study in High Surgical Risk TR Patients

The Intrepid TTVR Clinical Program

TCT 132: Impact of Comorbid Heart Failure With Reduced Ejection Fraction (HFrEF) in the Development of Arrhythmias Among Patients Hospitalized for Transcatheter Aortic Valve Replacement (TAVR)

The Cardiovalve TTVR Clinical Program

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

TCT 1483: LAMPOON-Assisted Transcatheter Mitral Valve-in-Valve Replacement

TCT 338: Clinical and Echocardiographic Predictors of Persistent Mitral Regurgitation Post Transcatheter Aortic Valve Replacement

TCT 1249: Endovascular Repair for Massive Iliac Vein Perforation During Trans-Septal Mitral Valve-in-Valve Replacement: Which Is the Culprit?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content